Buscar
Mostrando ítems 11-20 de 43
High sensitivity of chemiluminescent methodology for detection of clonal CDR3 sequences in patients with acute lymphoblastic leukemia
(2004)
Detection of minimal residual disease (MRD) in patients with B-cell acute lymphoblastic leukemia (B-ALL) has been achieved using several radioactive labelling methodologies; however, limited information exists about the ...
High sensitivity of chemiluminescent methodology for detection of clonal CDR3 sequences in patients with acute lymphoblastic leukemia
(2004)
Detection of minimal residual disease (MRD) in patients with B-cell acute lymphoblastic leukemia (B-ALL) has been achieved using several radioactive labelling methodologies; however, limited information exists about the ...
Comparison between flow cytometry and standard pcr in the evaluation of mrd in children with acute lymphoblastic leukemia treated with the gbtli lla - 2009 protocol
(Universidade Federal de Minas GeraisBrasilMED - DEPARTAMENTO DE PEDIATRIAMED - DEPARTAMENTO DE PROPEDÊUTICA COMPLEMENTARUFMG, 2019)
O monitoramento da doença residual mínima (DRM) é de importância prognóstica na leucemia linfoblástica aguda (LLA) infantil. A detecção de rearranjos gênicos de imunoglobulinas e receptores de células T por PCR quantitativo ...
Simplified flow cytometric assay to detect minimal residual disease in childhood with acute lymphoblastic leukemia
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2008)
The detection of minimal residual disease (MRD) is an important prognostic factor in childhood acute lymphoblastic leukemia (ALL) providing crucial information on the response to treatment and risk of relapse. However, the ...
Simplified flow cytometric assay to detect minimal residual disease in childhood with acute lymphoblastic leukemia
(Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, 2008-08-01)
The detection of minimal residual disease (MRD) is an important prognostic factor in childhood acute lymphoblastic leukemia (ALL) providing crucial information on the response to treatment and risk of relapse. However, the ...
Correlación del perfil genético con la enfermedad mínima residual al día 15 y al final de la inducción en niños menores de 18 años con diagnóstico de leucemia linfoide aguda de precursores b, en un centro de referencia
(Bogotá - Medicina - Especialidad en Oncohematología PediátricaUniversidad Nacional de Colombia - Sede Bogotá, 2019)
Background. It is recommended to assess cytogenetic testing in children with ALL. The prevalence of these results in colombian population is unknown, as well as the association of cytogenetic findings with Minimal Residual ...
An extensive Quality Control and Quality Assurance (QC/QA) Program significantly improves inter-laboratory concordance rates of flow-cytometric minimal residual disease assessment in acute lymphoblastic leukemia: an I-BFM-FLOW-Network report
(MDPI, 2021)
Simple Summary Standardization of flow-cytometric assessment of minimal residual disease in acute lymphoid leukemia (ALL) is necessary to allow concordant multicentric application of the methodology. This is a prerequisite ...